ANI Announces Etodolac Capsules Launch

Share this content:
Etodolac is a nonsteroidal anti-inflammatory drug (NSAID) indicated for acute and long-term use in the management of signs and symptoms ofosteoarthritis;and rheumatoid arthritis.
Etodolac is a nonsteroidal anti-inflammatory drug (NSAID) indicated for acute and long-term use in the management of signs and symptoms ofosteoarthritis;and rheumatoid arthritis.

ANI Pharmaceuticals announced the launch of Etodolac 200mg Capsules, formerly known under the brand name Lodine.

Etodolac is a nonsteroidal anti-inflammatory drug (NSAID) indicated for acute and long-term use in the management of signs and symptoms of osteoarthritis;and rheumatoid arthritis, and for the management of acute pain in adults.

The mechanism of action is unknown, but may be related to prostaglandin synthetase inhibition.

Etodolac Capsules are available in 200mg and 300mg strength hard gelatin capsules in 100-count bottles.

For more information visit AniPharmaceuticals.com.

You must be a registered member of Clinical Pain Advisor to post a comment.